Procter & Gamble Navigates a Pivotal Restructuring Phase

Procter & Gamble cuts 6% of its workforce and faces $400M in tariffs as it battles flat organic sales and consumer shift to private labels.

The consumer goods titan Procter & Gamble is navigating one of its most challenging market environments in recent memory. Confronted with stagnant organic sales and inflation-weary shoppers, the company has embarked on a significant strategic overhaul. This repositioning, marked by a workforce reduction plan and new leadership, is a direct response to mounting margin pressures and additional tariff costs.

Strategic Shifts Amid Consumer Pressure

Management, under the guidance of CEO Shailesh Jejurikar who assumed the role in January 2026, is implementing decisive measures to safeguard profitability. The cornerstone of this effort is a plan to eliminate approximately 6% of its global workforce—roughly 7,000 positions—over the next two years. This restructuring, which also involves exiting certain product categories, is expected to incur pre-tax charges of up to $1.6 billion. Compounding the financial headwinds, the company anticipates a post-tax tariff bill of about $400 million for the current fiscal year, stemming from imports of key raw materials and packaging from China.

The necessity for such action is clear from recent performance. While net sales saw a modest increase to $22.2 billion in the second fiscal quarter, organic growth flatlined completely. More concerning was a 1% contraction in sales volume. This trend is largely driven by price-sensitive consumers in the critical U.S. market, who are increasingly trading down to cheaper private-label alternatives. The Baby and Family Care segment has been notably impacted, recording a 4% decline in organic sales.

A Dual-Pronged Strategy: Premiumization and Regulatory Hurdles

In reaction to the shift toward value brands, P&G’s counter-strategy involves pushing premium innovations within its core portfolio, including major names like Pampers and Swiffer. A key question for investors is whether these upgraded products can successfully offset the volume losses in the company’s foundational categories.

Simultaneously, a regulatory challenge has emerged in Europe. The Italian competition authority has initiated a probe into advertising claims for a hair removal device under P&G’s Braun brand. The company has pledged full cooperation with the investigation, emphasizing its commitment to rigorous internal review processes.

Shareholder Returns Provide a Steadying Force

Despite the operational challenges, Procter & Gamble remains committed to returning capital to its shareholders. In the second quarter alone, the company funneled $4.8 billion back to investors through dividend payments and share repurchases. For the full 2026 fiscal year, management has reaffirmed its key financial targets:

• All-in sales growth: 1% to 5%
• Organic sales growth: 0% to 4%
• Planned dividend distributions: approximately $10 billion
• Planned share buybacks: around $5 billion

Market Sentiment and the Path Forward

The stock’s performance reflects this period of transition. Shares closed at €124.86 on Friday, representing a decline of 6.15% over the preceding 30-day period. This price sits just below the 50-day moving average of €130.93.

All eyes are now on the upcoming third-quarter earnings release scheduled for April 16. This report will offer the next critical data point for assessing the early impact of the restructuring program and whether the premiumization strategy is beginning to reverse the negative volume trend.